562 related articles for article (PubMed ID: 20141676)
1. NCCN clinical practice guidelines in oncology: prostate cancer.
Mohler J; Bahnson RR; Boston B; Busby JE; D'Amico A; Eastham JA; Enke CA; George D; Horwitz EM; Huben RP; Kantoff P; Kawachi M; Kuettel M; Lange PH; Macvicar G; Plimack ER; Pow-Sang JM; Roach M; Rohren E; Roth BJ; Shrieve DC; Smith MR; Srinivas S; Twardowski P; Walsh PC
J Natl Compr Canc Netw; 2010 Feb; 8(2):162-200. PubMed ID: 20141676
[No Abstract] [Full Text] [Related]
2. [Practice guideline 'Prostate cancer: diagnosis and treatment'].
de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308
[TBL] [Abstract][Full Text] [Related]
3. [Conference on the treatment of prostatic cancer. Munich, Germany, 2-3 November 1996].
Lansiaux P
Prog Urol; 1997 Dec; 7(6):1020-2. PubMed ID: 9490132
[No Abstract] [Full Text] [Related]
4. What your patient needs to know about prostate cancer.
Held-Warmkessel J
Nursing; 2002 Dec; 32(12):36-42; quiz N232. PubMed ID: 12468938
[No Abstract] [Full Text] [Related]
5. [Modern therapy of prostate cancer].
Kretschmer A; Stief C; Gratzke C
MMW Fortschr Med; 2014 Dec; 156(21-22):71-3. PubMed ID: 25608415
[No Abstract] [Full Text] [Related]
6. Serum prostate-specific antigen elevation in the post-radical prostatectomy patient.
Malkowicz SB
Urol Clin North Am; 1996 Nov; 23(4):665-75. PubMed ID: 8948419
[TBL] [Abstract][Full Text] [Related]
7. The prostate cancer conundrum.
Albertsen PC
J Natl Cancer Inst; 2003 Jul; 95(13):930-1. PubMed ID: 12837821
[No Abstract] [Full Text] [Related]
8. [Treatment for cancer specifically diagnosed in high-aged population, prostate cancer].
Miki T
Nihon Ronen Igakkai Zasshi; 2006 Jan; 43(1):71-3. PubMed ID: 16521807
[No Abstract] [Full Text] [Related]
9. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer.
Mohler JL
J Natl Compr Canc Netw; 2010 Feb; 8(2):145. PubMed ID: 20141674
[No Abstract] [Full Text] [Related]
10. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
11. Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it?
Klotz L
Curr Urol Rep; 2007 Sep; 8(5):341-4. PubMed ID: 17880830
[No Abstract] [Full Text] [Related]
12. NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.
Carroll PH; Mohler JL
J Natl Compr Canc Netw; 2018 May; 16(5S):620-623. PubMed ID: 29784740
[TBL] [Abstract][Full Text] [Related]
13. Salvage lymph node dissection in patients with prostate cancer treated with radical prostatectomy or radiotherapy and positive choline positron emission tomography (PET/CT) scan.
Otta-Oshiro RJ; Lista-Mateos F; García-Mediero J; Arranz-Arija JA; García-Prado J; Núñez-Mora C
Actas Urol Esp (Engl Ed); 2019; 43(6):331-335. PubMed ID: 30975547
[TBL] [Abstract][Full Text] [Related]
14. National Comprehensive Cancer Network guidelines for the management of prostate cancer.
Scherr D; Swindle PW; Scardino PT;
Urology; 2003 Feb; 61(2 Suppl 1):14-24. PubMed ID: 12667883
[TBL] [Abstract][Full Text] [Related]
15. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.
Fu AZ; Tsai HT; Haque R; Yood MU; Cassidy-Bushrow AE; Van Den Eeden SK; Keating NL; Smith MR; Zhou Y; Aaronson DS; Potosky AL
J Urol; 2017 Jun; 197(6):1448-1454. PubMed ID: 28007467
[TBL] [Abstract][Full Text] [Related]
16. Is prostate cancer screening responsible for the negative results of prostate cancer treatment trials?
Prasad V
Med Hypotheses; 2016 Aug; 93():71-3. PubMed ID: 27372859
[TBL] [Abstract][Full Text] [Related]
17. Further support for active surveillance in the management of low-volume, low-grade prostate cancer.
Albertsen P
Eur Urol; 2010 Dec; 58(6):836-7. PubMed ID: 20851512
[No Abstract] [Full Text] [Related]
18. SPCG-15: a prospective randomized study comparing primary radical prostatectomy and primary radiotherapy plus androgen deprivation therapy for locally advanced prostate cancer.
Stranne J; Brasso K; Brennhovd B; Johansson E; Jäderling F; Kouri M; Lilleby W; Meidahl Petersen P; Mirtti T; Pettersson A; Rannikko A; Thellenberg C; Akre O
Scand J Urol; 2018; 52(5-6):313-320. PubMed ID: 30585526
[TBL] [Abstract][Full Text] [Related]
19. Math may help to guide future prostate cancer treatments.
Printz C
Cancer; 2012 Mar; 118(5):1177. PubMed ID: 22344616
[No Abstract] [Full Text] [Related]
20. [Prostate cancer: synopsis of the American Urological Association (AUA) 2006].
Culty T; Richard F
Ann Urol (Paris); 2006 Dec; 40 Suppl 4():S107-22. PubMed ID: 17354516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
